Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome by Mingyuan Du, Cuiwei Liu, Leichong Chen, Zhenyu Li, Sijia Zhang, Rui Meng

Subjects: Get full text

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis by Jin Li, Ling Bai, Zhaodan Xin, Jiajia Song, Hao Chen, Xingbo Song, Juan Zhou

Subjects: Get full text

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation by Gelan Zhu, Jiayi Cai, Wanbin Fu, Yue Sun, Ting Wang, Hua Zhong

Subjects: Get full text

Variation characteristics and clinical significance of TP53 in patients with myeloid neoplasms by Qiang Ma, Yan Liu, Hong Zhao, Yixian Guo, Wanling Sun, Ronghua Hu

Subjects: Get full text

MGAT4A/Galectin9‐Driven N‐Glycosylation Aberration as a Promoting Mechanism for Poor Prognosis of Endometrial Cancer with TP53 Mutation by Zhen Zhu, Jingya Sun, Weiqing Xu, Qinghe Zeng, Hanyi Feng, Lijuan Zang, Yinyan He, Xiao He, Na Sheng, Xuelian Ren, Guobin Liu, He Huang, Ruimin Huang, Jun Yan

Subjects: Get full text

Genetic Profiling in Chronic Lymphocytic Leukemia: The Role of TP53 Mutations and IGHV Status in Treatment Decision-Making – A Case Report by Kateryna Khurdepa, Oksana Karnabeda

Subjects: Get full text

A Case of Lung Squamous Cell Carcinoma Harboring TP53 Mutation and PLPP5‐FGFR1 Fusion Gene by Meng Xiao‐ru, Shi Xiao‐Xiong, Gao Qian, Qu Ya‐jing, Huo Li‐li, Gao Yan‐Yan, Xu Peng‐peng, Ma Guan‐nan, Ren Gui‐bing

Subjects: Get full text

Targeting the JAK2–STAT3–UCHL3–ENO1 axis suppresses glycolysis and enhances the sensitivity to 5-FU chemotherapy in TP53-mutant colorectal cancer by Haisong Xin, Zitong Zhao, Shichao Guo, Ruoxi Tian, Liying Ma, Yang Yang, Lianmei Zhao, Guanglin Wang, Baokun Li, Xuhua Hu, Yongmei Song, Guiying Wang

Subjects: Get full text

Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma by Stephanie Cham, Niya Xiong, Nabihah Tayob, Carolyn Krasner, Alexi A. Wright, Elizabeth K. Lee, Hannah Sawyer, Cara Mathews, Panagiotis A. Konstantinopoulos, Ursula A. Matulonis, Joyce F. Liu

Subjects: Get full text

Decoding the molecular landscape: HER2 and PD-L1 in advanced gastric cancer by Jun Yao, Qiang Sun, Han Wu, Xiaokai Zhao, Pengmin Yang, Xiaozhi Wang, Xintao Wang, Meiping Gu, Jieyi Li, Yuansi Zheng, Ziying Gong, Daoyun Zhang, Weijun Wang

Subjects: Get full text

TP53-mutated MDS and AML: immune dysregulation, tumor microenvironment, and emerging therapeutic strategies by Marwah M. Albakri, Marwah M. Albakri

Subjects: “…TP53 mutation…”
Get full text

Penile Cancer Distant Metastasis or Primary Lung Cancer? Using Focused Genomic Profiling of Tumor and Germline Mutations With Next‐Generation Sequencing for Clinical Decision‐Makin... by Christian A. Moen, Ida M. Nordanger, Ása Karlsdóttir, Alfred Honoré, Patrick Juliebø‐Jones, Siri M. Blomberg, Torjan M. Haslerud, Christina Aamelfot, Pirjo‐Riitta Salminen, Christian Beisland, Hildegunn H. Vetti, Daniela E. Costea, Ellen Berget

Subjects: Get full text

Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker by Meejeong Kim, Gyeong Sin Park, Kyo Young Lee, Seok Whan Moon, Yeoun Eun Sung

Subjects: Get full text

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysisResearch in context by Na Zhang, Jiegang Xu, Chengxin Luo, Rushuang Xu, Yan Zeng, Dongfeng Zeng, Shuangnian Xu, Xi Li

Subjects: Get full text

Expanding clinicopathologic knowledge in high-grade glioma with pleomorphic and pseudopapillary features (HPAP): a report of two cases by Sabrina Rossi, Isabella Giovannoni, Sara Patrizi, Andrea Mafficcini, Eleonora Piccirilli, Giuseppe Kenneth Ricciardi, Giacomina Megaro, Francesca Arienzo, Chantal Tancredi, Emanuele Agolini, Andrea Carai, Angela Mastronuzzi, Caterina Giannini, Franco Locatelli, Rita Alaggio, Giovanna Stefania Colafati, Viola Alesi, Evelina Miele, Valeria Barresi

Subjects: Get full text

The Critical Role of TP53 in Developing Leukaemia in Human and Dogs, Review Article by ِAoula Al-Zebeeby, Fatimah Abdulmuttaleb Ali

Subjects: Get full text

Plasma ctDNA TP53 Mutation and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis by FAN Hao, LIANG Annan, ZOU Wei, GAO Guangxi, LIU Lijin, LIU Fei, ZHAO Lina, WU Zhihong

Subjects: “…tp53 mutations…”
Get full text

Prediction of Therapeutic Response and Prognosis in Ovarian Cancer Patients With Plasma Circulating Biomarkers by Haixia Cheng, Guangwen Yuan, Leilei Liang, Tiantian Wang, Jiarun Zhu, Hongying Yang, Zhendiao Zhou, Pei Wang, Qianqian Song, Yuchen Jiao, Mei Liu, Lingying Wu

Subjects: Get full text

Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6 by Mingzhen Bai, Ruoshui Wang, Chongfei Huang, Ruyang Zhong, Ningzu Jiang, Wenkang Fu, Ningning Mi, Long Gao, Yuyao Jin, Haidong Ma, Jie Cao, Haiying Yu, Qiang Jing, Chao Zhang, Ping Yue, Yong Zhang, Yanyan Lin, Hengwei Zhang, Wenbo Meng

Subjects: Get full text

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era by Jaime Rubio-Perez, Roberto Hernandez, Carlota Santolaya, Maria Cruz Martin-Soberon, Sandra Zazo, Nerea Carvajal, Federico Rojo

Subjects: Get full text